Huntsman’s Q2 2026: A Narrowing Loss, EBITDA’s Bright Spot, and an All-Stock Olin Tie

Executive snapshot

The quarter delivered a dramatic contrast to a year ago. GAAP net loss narrowed to $6 million from a $158 million loss in the prior year period, while diluted loss per share came in at $(0.03), versus $(0.92) in the year-ago quarter. On an adjusted basis, the company reports nil earnings per share (adjusted net income of zero) versus an adjusted loss per share of $(0.20) in the prior year period.

One of the standout metrics is adjusted EBITDA, which rose to $120 million from $74 million in the prior year period, signaling improved operating performance even as GAAP metrics remained sensitive to non-operating items and capital structure. Cash flow tells a mixed story: net cash used in operating activities from continuing operations was $60 million, and free cash flow was a use of $90 million in Q2 2026, compared with a cash source of $55 million in the prior year period.

The press materials note the June 16, 2026 announcement of a complete all-stock merger of equals with Olin Corporation, a development that reorients both companies’ capital allocation and growth trajectory. For readers tracking the stock’s reaction or the potential for earnings surprises, the absence of a stated revenue forecast in the release means investors will be leaning on EBITDA and cash-flow signals, with the merger dynamics adding a new layer of complexity to earnings per share (EPS) trajectories.

• Ticker: HUN
• EPS: diluted loss per share of $0.03; adjusted EPS nil
• earnings surprise: not explicitly disclosed as a formal consensus beat/made-for-market surprise
• EPS consensus: not provided in the release
• revenue forecast: not provided in the quarter’s disclosures

Second-quarter highlights

The company emphasizes a strong swing in profitability on an adjusted basis, with adjusted EBITDA reaching $120 million, up from $74 million in the prior year period. The GAAP net income line benefited from improvements in operating performance, but cash flow remained a challenge in the quarter, reflecting working-capital timing and the near-term impact of the ongoing corporate restructuring and M&A activity.

A simple way to view the quarter: a better EBITDA pace, a tighter GAAP loss, and capital-structure changes that push the narrative away from simple quarter-to-quarter cash generation and toward longer-horizon value creation from scale and synergy.

All-stock merger of equals with Olin: what this changes

The June 16 announcement of a complete all-stock merger of equals with Olin Corporation is the headline here. Stock-for-stock arrangements shift the risk–return profile away from cash outlays toward equity-based alignment. In practical terms, the combined entity would gain scale, likely broaden product coverage, and potentially unlock synergies across polymer chemistries, coatings, and specialty materials. But it also raises questions about timing, integration risk, and how the combined cost structure translates into free cash flow after the deal closes.

For investors, this is a classic equity-structure pivot: you trade some near-term cash flow clarity for longer-term scale and potential synergies. If the anticipated benefits materialize, the post-merger earnings profile could improve meaningfully, but the path from EBITDA to sustainable cash flow will be the true test, especially given the all-stock nature of consideration.

Sector peers will watch closely how Huntsman and Olin position the combined entity: will the deal catalyze a wave of consolidation in specialty chemicals, or will it become a one-off rebalancing that leaves the competitive landscape largely intact? Either way, the move underlines a market appetite for scale as a vehicle for earnings resilience in a volatile input-cost environment.

Outlook for Huntsman and sector peers

The lack of an explicit quarterly revenue forecast in the release means investors will calibrate expectations primarily through EBITDA, adjusted earnings metrics, and the progress of the Olin merger. If the combination delivers the anticipated efficiency gains and product diversification, the next few quarters could turn EBITDA momentum into firmer cash generation. The negative free cash flow in Q2 highlights the ongoing need for working-capital discipline and a favorable cadence in capital expenditures and integration costs.

For peers, the message is threefold. First, scale remains a durable growth vector in chemicals; second, stock-based deal structures are increasingly used to bridge value without immediate cash outlays; and third, attention to EPS trajectory and any visible earnings surprise will be central to how the market prices these stories in a high-multiple, capital-intensive sector. If the Olin deal closes as envisioned, the sector may see a re‑rating of peers that pursue aggressive agglomeration strategies.

Risks and key watch items

• Deal execution risk: regulatory approvals, integration timelines, and the management of two corporate cultures in one entity.
• Working capital and cash conversion: Q2’s negative free cash flow suggests a need for efficiency in capital use as the merger progresses.
• Commodity sensitivity: input costs for polymers and coatings can swing margins, affecting how quickly EBITDA translates into cash flow.
• Market expectations: EPS consensus and any forward-looking revenue guidance will shape how the stock responds to near-term earnings visibility.

Bottom line

Huntsman’s Q2 2026 results portray a company moving from loss toward stability, with EBITDA strengthening and cash flow dynamics still in flux ahead of a transformative merger. The all-stock tie-up with Olin adds a fresh lens for evaluating value creation—one that hinges on integration success, synergies, and a disciplined return of capital to shareholders. For readers watching the EPS line, the emergence of a positive or at least stable earnings trajectory will be a critical signal as the sector digests the implications of these corporate moves.